Text and Data Mining valid from 2018-01-29
Received: 15 September 2017
Accepted: 4 January 2018
First Online: 29 January 2018
: OLW is a shareholder in Armaron Bio, a company which aims to develop flavonols for the treatment of cardiovascular disease. The other authors have nothing to disclose.